218 related articles for article (PubMed ID: 35610740)
21. Oral and ocular manifestations in Sjögren's syndrome.
Kalk WW; Mansour K; Vissink A; Spijkervet FK; Bootsma H; Kallenberg CG; Roodenburg JL; Nieuw Amerongen AV
J Rheumatol; 2002 May; 29(5):924-30. PubMed ID: 12022351
[TBL] [Abstract][Full Text] [Related]
22. The European Community Study Group on diagnostic criteria for Sjögren's syndrome. Sensitivity and specificity of tests for ocular and oral involvement in Sjögren's syndrome.
Vitali C; Moutsopoulos HM; Bombardieri S
Ann Rheum Dis; 1994 Oct; 53(10):637-47. PubMed ID: 7979575
[TBL] [Abstract][Full Text] [Related]
23. Pro- and anti-inflammatory forms of interleukin-1 in the tear fluid and conjunctiva of patients with dry-eye disease.
Solomon A; Dursun D; Liu Z; Xie Y; Macri A; Pflugfelder SC
Invest Ophthalmol Vis Sci; 2001 Sep; 42(10):2283-92. PubMed ID: 11527941
[TBL] [Abstract][Full Text] [Related]
24. Tear lipid layer thickness and ocular comfort with a novel device in dry eye patients with and without Sjögren's syndrome.
Spiteri A; Mitra M; Menon G; Casini A; Adams D; Ricketts C; Hickling P; Fuller ET; Fuller JR
J Fr Ophtalmol; 2007 Apr; 30(4):357-64. PubMed ID: 17486027
[TBL] [Abstract][Full Text] [Related]
25. Sjögren's Syndrome: More Than Just Dry Eye.
Akpek EK; Bunya VY; Saldanha IJ
Cornea; 2019 May; 38(5):658-661. PubMed ID: 30681523
[TBL] [Abstract][Full Text] [Related]
26. Tear Proteomics Approach to Monitoring Sjögren Syndrome or Dry Eye Disease.
Kuo MT; Fang PC; Chao TL; Chen A; Lai YH; Huang YT; Tseng CY
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31010136
[TBL] [Abstract][Full Text] [Related]
27. Elevation of autophagy markers in Sjögren syndrome dry eye.
Byun YS; Lee HJ; Shin S; Chung SH
Sci Rep; 2017 Dec; 7(1):17280. PubMed ID: 29222450
[TBL] [Abstract][Full Text] [Related]
28. Prevalence and predictors of Sjogren's syndrome in a prospective cohort of patients with aqueous-deficient dry eye.
Liew MS; Zhang M; Kim E; Akpek EK
Br J Ophthalmol; 2012 Dec; 96(12):1498-503. PubMed ID: 23001257
[TBL] [Abstract][Full Text] [Related]
29. Meibomian gland atrophy with duration of Sjogren's syndrome in adult females.
Noh SR; Chung JL; Lee JM; Seo KY; Koh K
Int Ophthalmol; 2022 Jan; 42(1):191-200. PubMed ID: 34409540
[TBL] [Abstract][Full Text] [Related]
30. Utility of Novel Autoantibodies in the Diagnosis of Sjögren's Syndrome Among Patients With Dry Eye.
Karakus S; Baer AN; Agrawal D; Gurakar M; Massof RW; Akpek EK
Cornea; 2018 Apr; 37(4):405-411. PubMed ID: 29504954
[TBL] [Abstract][Full Text] [Related]
31. Topical cyclosporine a (0.05%) treatment in dry eye patients: a comparison study of Sjogren's syndrome versus non-Sjogren's syndrome.
Cubuk MO; Ucgul AY; Ozgur A; Ozulken K; Yuksel E
Int Ophthalmol; 2021 Apr; 41(4):1479-1485. PubMed ID: 33484384
[TBL] [Abstract][Full Text] [Related]
32. Outcomes of Sjögren's versus non-Sjögren's related dry eye in a longitudinal, tertiary clinic-based sample.
Cui D; Mathews P; Li G; VanCourt S; Akpek E
PLoS One; 2021; 16(12):e0261241. PubMed ID: 34919587
[TBL] [Abstract][Full Text] [Related]
33. The Efficacy of Diquafosol Ophthalmic Solution in Non-Sjögren and Sjögren Syndrome Dry Eye Patients Unresponsive to Artificial Tear.
Jeon HS; Hyon JY
J Ocul Pharmacol Ther; 2016 Sep; 32(7):463-8. PubMed ID: 27294831
[TBL] [Abstract][Full Text] [Related]
34. Reduced Levels of Tear Lacritin Are Associated With Corneal Neuropathy in Patients With the Ocular Component of Sjögren's Syndrome.
McNamara NA; Ge S; Lee SM; Enghauser AM; Kuehl L; Chen FY; Gallup M; McKown RL
Invest Ophthalmol Vis Sci; 2016 Oct; 57(13):5237-5243. PubMed ID: 27711909
[TBL] [Abstract][Full Text] [Related]
35. Importance of tear volume for positivity of tear matrix metalloproteinase-9 immunoassay.
Jun JH; Lee YH; Son MJ; Kim H
PLoS One; 2020; 15(7):e0235408. PubMed ID: 32649686
[TBL] [Abstract][Full Text] [Related]
36. Corneal subbasal nerve analysis in patients with primary Sjogren's syndrome: a novel objective grading method and clinical correlations.
Hao R; Chou Y; Ding Y; Liu Z; Wang Y; Ren X; Li X
Int Ophthalmol; 2023 Mar; 43(3):779-793. PubMed ID: 36056289
[TBL] [Abstract][Full Text] [Related]
37. Characteristics of dry eye in patients with pre-existing Sjögren's syndrome according to the revised 2016 ACR-EULAR classification criteria.
Yoon HJ; Choi W; Yang JM; Ji YS; Lee SS; Yoon KC
Medicine (Baltimore); 2019 Mar; 98(9):e14641. PubMed ID: 30817584
[TBL] [Abstract][Full Text] [Related]
38. An Overview of the Dry Eye Disease in Sjögren's Syndrome Using Our Current Molecular Understanding.
Wu KY; Kulbay M; Tanasescu C; Jiao B; Nguyen BH; Tran SD
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675090
[TBL] [Abstract][Full Text] [Related]
39. Different perception of dry eye symptoms between patients with and without primary Sjogren's syndrome.
Kim M; Chun YS; Kim KW
Sci Rep; 2022 Feb; 12(1):2172. PubMed ID: 35140286
[TBL] [Abstract][Full Text] [Related]
40. Tear cathepsin S as a candidate biomarker for Sjögren's syndrome.
Hamm-Alvarez SF; Janga SR; Edman MC; Madrigal S; Shah M; Frousiakis SE; Renduchintala K; Zhu J; Bricel S; Silka K; Bach D; Heur M; Christianakis S; Arkfeld DG; Irvine J; Mack WJ; Stohl W
Arthritis Rheumatol; 2014 Jul; 66(7):1872-81. PubMed ID: 24644101
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
